Processa Pharmaceuticals (PCSA) SEC Filings & 10K Form

$1.96
-0.04 (-2.00%)
(As of 05/17/2024 08:54 PM ET)

Recent Processa Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/12/2024
3:57 PM
Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
4:01 PM
Processa Pharmaceuticals (Issuer)
Young David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:50 PM
Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:52 PM
Bigora Sian (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:55 PM
Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
7:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
11:05 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
4:25 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
3:22 PM
Processa Pharmaceuticals (Issuer)
Young David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
7:30 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
5:32 PM
Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:34 PM
Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:37 PM
Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
9:46 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2024
11:15 PM
Processa Pharmaceuticals (Filer)
Form EFFECT
01/25/2024
7:35 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
7:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:30 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:30 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
7:55 AM
Processa Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/19/2023
8:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
4:18 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
2:10 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
10:30 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
1:45 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
4:31 PM
Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
Form 4/A
10/16/2023
8:15 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
4:56 PM
Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
4:58 PM
Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
5:01 PM
Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
5:04 PM
Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
5:07 PM
Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
4:54 PM
Processa Pharmaceuticals (Issuer)
Young David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:00 PM
Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:03 PM
Processa Pharmaceuticals (Issuer)
Young David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
4:05 PM
Pannu Geraldine (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:51 PM
Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
9:00 AM
Processa Pharmaceuticals (Filer)
Form DEF 14A
10/05/2023
9:01 AM
Processa Pharmaceuticals (Filer)
Form DEFA14A
09/25/2023
3:09 PM
Processa Pharmaceuticals (Filer)
Form PRE 14A
09/21/2023
4:29 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Next President (Not Trump. Not Biden.) (Ad)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.
08/17/2023
11:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
9:30 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
5:35 PM
Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
5:38 PM
Neal James R (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
5:26 PM
Pannu Geraldine (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
5:29 PM
Baluch Khoso (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
5:33 PM
Processa Pharmaceuticals (Issuer)
THOMPSON VIRGIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
3:18 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
11:30 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2023
1:05 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PCSA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners